Holland Capital invests in Data platform for medical research
Amsterdam/Düsseldorf, 19 December 2023 – Holland Capital invests in German company Honic for further development of their medical data platform.
Using this funding, Honic is able to further roll out its medical data platform. The platform – developed in cooperation with the German privacy regulator and various patient groups – is live since early 2022. The first research projects with universities and international life science companies have already been successfully conducted and completed. In cooperation with renowned partners such as Bundesdruckerei as data handler, IT security company Secunet, and Schwarz Group’s cloud provider StackIT, Honic offers a completely independent solution with its data platform.
Holland Capital led this funding round. Existing investors such as Dieter von Holtzbrinck Ventures, adesso Ventures and Isartal Ventures also participated in this round.
“In recent months, we have shown that the Honic platform is capable of making routinely collected medical data from routine care available for further research. With Holland Capital’s investment, we will further expand the Honic data infrastructure and unlock new data sources to play a pivotal role in the emerging European Health Data Space (EHDS),” said dr. Henrik Matthies, CEO and co-founder of Honic.
“Honic is unique in the European health tech scene as it has been able to develop a data infrastructure aligned with the privacy regulator that can enable large-scale, interdisciplinary medical research. This enables medical research using routinely collected data which is aggregated from different sources . We are delighted to be involved in the next phase of Honic,” said Jan-Frens van Giessel, partner at Holland Capital.
“Holland Capital reinforces Honic’s mission to expand medical science in Germany and Europe. In addition to its financial investment, Holland Capital’s team also supports us with their vast experience and expertise. I am very pleased that we were able to attract international experts such as Harm-Jan Wessels and Achim Plückebaum for the board of Honic,” said Prof. med Jörg F. Debatin, MBA, chairman of the board and co-founder of Honic.
About Honic
Honic was founded by dr. Henrik Matthies and prof. dr. med J. F. Debatin, MBA. The platform, developed in cooperation with the privacy regulator in Germany, uses a unique concept allowing anonymized medical data to be aggregated to generate “Real World” insights for medical research. Since 2022, the platform has been live and successful research projects with universities and international life science companies have been conducted.
About Holland Capital
Over the past 40 years Holland Capital has invested responsibly and successfully in more than 180 Dutch SMEs. With a clear investment strategy it is active in the attractive growth markets Healthcare, Technology and Agrifood. The experienced and committed investment team knows what entrepreneurship is all about. It aims for an open, sustainable and professional relationship with the management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Magnus accelerates growth through collaboration with Holland Capital
Magnus accelerates growth through collaboration with Holland Capital Amsterdam / Naarden, November 26, 2020 - Holland Capital invests in consultancy company Magnus, a major player in the field of digital transformation. With its broad IT expertise, Magnus is a...
Holland Capital invests in AMP Groep, an innovative service provider in logistics and identification
Holland Capital invests in AMP Groep, an innovative service provider in logistics and identification Amsterdam / Houten, October 6th, 2020 – Investment firm Holland Capital invests in AMP Groep, an innovative service provider active in the logistics and identification...
U-Needle secures growth financing for the global rollout of its Bella-mu product range
Amsterdam/Enschede, 1st of October 2020 – Holland Capital invests in U-Needle with Waterman Ventures and along with existing shareholders including UT International Ventures incubator fund. U-Needle has developed Bella-mu, a range of needles created for intradermal...
Yenlo and Fides join forces
Amsterdam, 21 September 2020 – Our portfolio company Yenlo (the integration specialist in the field of API and ESB technology) and Fides (the AFAS migration and integration partner for healthcare and education) join forces to support the integration for customers with...
Holland Capital invests in innovative primary care IT platform HealthConnected
Amsterdam/Alkmaar, September 1st, 2020 – Holland Capital, a Dutch based investment firm, invests in HealthConnected, a healthcare IT platform for the primary care market. This investment enables HealthConnected to focus on the expansion to new regions in the...
Sirius Medical raises €4.4M to launch Sirius Pintuition
Sirius Medical raises €4.4M to launch Sirius PintuitionAn innovative breast cancer localization technology Amsterdam, July 14th, 2020 – Investment company Holland Capital invests 4.4 million euros in Sirius Medical together with BOM Brabant Ventures and Curie Capital....
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl